Needham & Company LLC Reaffirms Buy Rating for Neumora Therapeutics (NASDAQ:NMRA)
Needham & Company LLC restated their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a $5.00 target price on the stock. A number of other brokerages have also issued reports on NMRA. HC Wainwright reiterated a “buy” rating and […]
Needham & Company LLC restated their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a $5.00 target price on the stock. A number of other brokerages have also issued reports on NMRA. HC Wainwright reiterated a “buy” rating and […]
